[ORGANIZATION]
Medpace
Featured in 3 tracked stories · first seen
Situations
FDA rare disease drug development reform
3 clusters · 10 sources · last updated
Latest: FDA launches initiative to standardize rare disease drug reviews
The U.S. Food and Drug Administration (FDA) has launched the ‘Rare Disease Framework Initiative’ to redesign the development and review process for drugs and biologics targeting rare conditions. The initiative seeks to m
Also covered in
-
Corporate earnings reports released for multiple sectors
[BUSINESS] · 2 sources ·
-
Rheumatology trends focus on CAR T-cell therapy and integrative wellness
[HEALTH] · 2 sources ·